How to solve R&D productivity challenges
It's no secret that R&D and innovation teams are being squeezed harder. In 2017, R&D investments in the pharmaceutical space reached more than $70 billion and they will reach over $200 billion by 2024. Pharma is one of the two sectors that are heavily reinvesting its revenue in research and development (15% to 20% on average). Considering the cost associated to the development of a new drug and to bring it to market, the return on investment is declining sharply, according to a Deloitte 2018 report. And if we take a look to the expiration of drug patent, the revenues will cut. This makes the need to spend aggressively to enter highly competitive (and uncertain) markets.
6 Ways to Improve R&D Strategy
1. Priority ManagementOne of the problems in R&D organizations is that priorities are not the same whether you ask researchers, marketers, or shareholders. So, before adopting a diversification strategy, or a consolidation strategy, companies should address the misalignment that may exist between departments and growth goals, like:
2. Process Management Optimization
Improving, standardizing, and automating processes result in higher overall R&D efficiency and also the entire organization, its supply chain, and its customers. This process optimization can lead to:
3. Quality Management
By putting quality systems and risk assessment center stage, companies are better positioned to design and develop a product of consistent quality while reducing costs associated with mitigating low-risk categories.
4. Use Big Data Strategies
Big data in life sciences data analytics has taken large precedence. Data in the healthcare space comes from a wide variety of sources, from R&D downstream to patients and their caregivers. This considerable volume of data that holds valuable insights can help in:
5. Data Integrity Strategy
6. New Strategic Alliances
We all know that inefficiencies are driving up R&D costs in all pharma and biotech companies, regardless of size.
,
Share this article
|